Alexa maintains a general litigation practice, with a particular interest in health care, life sciences, and probate matters. She originally joined Mintz as a Summer Associate, during which time she developed a strong foundation in health law and regulatory policy.
Prior to working at Mintz, Alexa completed a legal / regulatory internship at the US Food and Drug Administration’s Center for Drug Evaluation and Research. Her work focused on issues under the Federal Food, Drug, and Cosmetic Act and related regulatory frameworks. She also has experience supporting family law practice and conducting research on the ethical and legal implications of emerging biotechnologies.
Alexa earned her JD from Vanderbilt University Law School, where she was president of the Health Law Society. During law school, she contributed to the Vanderbilt Journal of Transnational Law and published an article on DNA testing for family reunification. Prior to law school, she earned a BS in human biology and society from UCLA.
Alexa is based in the Boston office.
viewpoints
PBM Challenges Public Disclosure Laws in Texas to Protect Confidential Information
June 23, 2026 | Blog | By Rachel A. Alexander, Theresa Carnegie, Jacob Hupart, Xavier Hardy, Alexa Greco
On June 9, 2026, Express Scripts, Inc. (Express Scripts) filed an action against the Attorney General of the State of Texas, Ken Paxton, seeking a declaratory judgment to prevent the Texas A&M University System (Texas A&M) from releasing an unredacted version of a contract between Express Scripts and Texas A&M. Following a public information request for the contract, Express Scripts had proposed redactions to shield what it characterizes as (1) trade secrets and confidential commercial and financial information (including pricing, response times, and programmatic details), and (2) personal information of individuals (such as signatures and initials). The Texas Office of the Attorney General (OAG) reviewed the proposed redactions and, in a ruling dated June 2, 2026, concluded that the contract must be released in its entirety without any redactions. The OAG determined that, under relevant Texas state law, state agencies are required to post vendor contracts on their websites (Government Code § 2261.253(a)(1)), and that the trade secret and confidential information exemptions present in Texas state law do not apply here (Government Code § 552.0222(b)(1)). The OAG further held that common-law privacy could not serve as a basis to withhold information that is specifically made public by statute.
Qui Tam Quandaries: False Claims Act at a Constitutional Crossroads — EnforceMintz
January 20, 2026 | Article | By Grady Campion, Alexa Greco, Clare Prober
Explore key constitutional challenges to the False Claims Act, including Article II disputes over qui tam provisions and Excessive Fines Clause litigation. Learn how recent court decisions impact FCA enforcement and penalty limits in 2026.
Recent Insights
